Related Experiment Videos

Chalk and cheese: symptomatic hypocalcaemia during paediatric anti-tuberculous therapy

David Burgner1, Elisabeth Schölvinck, Michael Coren

  • 1School of Paediatrics and Child Health, University of Western Australia, Princess Margaret Medical Centre, WA, Australia. dburgner@paed.uwa.edu.au

Insights

Standard anti-tuberculosis drugs can disrupt vitamin D and calcium levels in children. This case study highlights hypocalcaemia in two pediatric patients due to these therapies, emphasizing the need for monitoring.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Infectious Diseases

Background:

  • Standard anti-tuberculosis therapy is crucial for treating Mycobacterium tuberculosis infections.
  • Vitamin D metabolism and calcium homeostasis are vital for overall health.
  • Disruption of these metabolic pathways can lead to significant health issues.

Observation:

  • Two pediatric patients undergoing anti-tuberculosis treatment presented with symptomatic hypocalcaemia.
  • The hypocalcaemia was found to be secondary to hypovitaminosis D.
  • Rifampicin and isoniazid were identified as the likely precipitating agents.

Findings:

  • Anti-tuberculosis drugs, specifically rifampicin and isoniazid, can adversely affect vitamin D metabolism in children.
  • This disruption can lead to clinically significant hypocalcaemia.
  • This interaction is previously unreported in the pediatric population.

Implications:

  • Clinicians should be aware of the potential for vitamin D and calcium disturbances in children treated for tuberculosis.
  • Monitoring of vitamin D and calcium levels may be warranted during anti-tuberculosis therapy.
  • Further research is needed to elucidate the mechanisms and prevalence of this interaction.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...